nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—UGT2B7—urinary bladder cancer	0.513	1	CbGaD
Morphine—UGT2B7—Epirubicin—urinary bladder cancer	0.0589	0.256	CbGbCtD
Morphine—UGT1A1—Etoposide—urinary bladder cancer	0.0396	0.172	CbGbCtD
Morphine—ABCB1—Mitomycin—urinary bladder cancer	0.0383	0.166	CbGbCtD
Morphine—CYP3A4—Thiotepa—urinary bladder cancer	0.0174	0.0755	CbGbCtD
Morphine—CYP2C8—Fluorouracil—urinary bladder cancer	0.0139	0.0605	CbGbCtD
Morphine—CYP2C8—Etoposide—urinary bladder cancer	0.0116	0.0505	CbGbCtD
Morphine—ABCB1—Gemcitabine—urinary bladder cancer	0.011	0.0479	CbGbCtD
Morphine—ABCB1—Cisplatin—urinary bladder cancer	0.008	0.0348	CbGbCtD
Morphine—ABCB1—Etoposide—urinary bladder cancer	0.00786	0.0342	CbGbCtD
Morphine—ABCB1—Doxorubicin—urinary bladder cancer	0.00536	0.0233	CbGbCtD
Morphine—ABCB1—Methotrexate—urinary bladder cancer	0.0052	0.0226	CbGbCtD
Morphine—CYP2D6—Doxorubicin—urinary bladder cancer	0.00505	0.022	CbGbCtD
Morphine—CYP3A4—Etoposide—urinary bladder cancer	0.00471	0.0205	CbGbCtD
Morphine—UGT1A1—urine—urinary bladder cancer	0.00395	0.127	CbGeAlD
Morphine—CYP3A4—Doxorubicin—urinary bladder cancer	0.00321	0.014	CbGbCtD
Morphine—UGT2B15—prostate gland—urinary bladder cancer	0.00273	0.0878	CbGeAlD
Morphine—UGT1A8—renal system—urinary bladder cancer	0.00222	0.0714	CbGeAlD
Morphine—UGT2B15—urethra—urinary bladder cancer	0.00183	0.0588	CbGeAlD
Morphine—OPRL1—female reproductive system—urinary bladder cancer	0.00173	0.0558	CbGeAlD
Morphine—Ethylmorphine—POR—urinary bladder cancer	0.00172	0.539	CrCbGaD
Morphine—UGT2B7—prostate gland—urinary bladder cancer	0.00167	0.0537	CbGeAlD
Morphine—OPRK1—prostate gland—urinary bladder cancer	0.00157	0.0504	CbGeAlD
Morphine—UGT2B15—female reproductive system—urinary bladder cancer	0.00149	0.0479	CbGeAlD
Morphine—UGT1A1—prostate gland—urinary bladder cancer	0.00142	0.0456	CbGeAlD
Morphine—CYP3A4—urine—urinary bladder cancer	0.00127	0.0407	CbGeAlD
Morphine—CYP2D6—urine—urinary bladder cancer	0.00125	0.0401	CbGeAlD
Morphine—UGT2B7—renal system—urinary bladder cancer	0.00114	0.0366	CbGeAlD
Morphine—Codeine—UGT2B7—urinary bladder cancer	0.00111	0.35	CrCbGaD
Morphine—OPRD1—renal system—urinary bladder cancer	0.00111	0.0359	CbGeAlD
Morphine—OPRL1—lymph node—urinary bladder cancer	0.00101	0.0326	CbGeAlD
Morphine—UGT1A1—renal system—urinary bladder cancer	0.000966	0.0311	CbGeAlD
Morphine—UGT2B7—female reproductive system—urinary bladder cancer	0.00091	0.0293	CbGeAlD
Morphine—OPRK1—female reproductive system—urinary bladder cancer	0.000856	0.0275	CbGeAlD
Morphine—CYP2C8—renal system—urinary bladder cancer	0.000457	0.0147	CbGeAlD
Morphine—CYP2C8—female reproductive system—urinary bladder cancer	0.000366	0.0118	CbGeAlD
Morphine—Naloxone—ESR1—urinary bladder cancer	0.000353	0.111	CrCbGaD
Morphine—CYP2C8—vagina—urinary bladder cancer	0.000331	0.0107	CbGeAlD
Morphine—ABCB1—prostate gland—urinary bladder cancer	0.000322	0.0103	CbGeAlD
Morphine—CYP3A4—renal system—urinary bladder cancer	0.00031	0.00997	CbGeAlD
Morphine—CYP2D6—renal system—urinary bladder cancer	0.000305	0.00981	CbGeAlD
Morphine—ABCB1—seminal vesicle—urinary bladder cancer	0.000272	0.00875	CbGeAlD
Morphine—CYP3A4—female reproductive system—urinary bladder cancer	0.000248	0.00798	CbGeAlD
Morphine—CYP2D6—female reproductive system—urinary bladder cancer	0.000244	0.00785	CbGeAlD
Morphine—ABCB1—epithelium—urinary bladder cancer	0.000236	0.00761	CbGeAlD
Morphine—ABCB1—renal system—urinary bladder cancer	0.000219	0.00705	CbGeAlD
Morphine—ABCB1—urethra—urinary bladder cancer	0.000215	0.00693	CbGeAlD
Morphine—ABCB1—female reproductive system—urinary bladder cancer	0.000176	0.00565	CbGeAlD
Morphine—ABCB1—vagina—urinary bladder cancer	0.000159	0.00511	CbGeAlD
Morphine—ABCB1—lymph node—urinary bladder cancer	0.000103	0.0033	CbGeAlD
Morphine—Urticaria—Etoposide—urinary bladder cancer	6.08e-05	0.000507	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—urinary bladder cancer	6.07e-05	0.000506	CcSEcCtD
Morphine—Rhinitis—Epirubicin—urinary bladder cancer	6.06e-05	0.000505	CcSEcCtD
Morphine—Abdominal pain—Etoposide—urinary bladder cancer	6.05e-05	0.000505	CcSEcCtD
Morphine—Body temperature increased—Etoposide—urinary bladder cancer	6.05e-05	0.000505	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—urinary bladder cancer	6.05e-05	0.000505	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—urinary bladder cancer	6.05e-05	0.000505	CcSEcCtD
Morphine—Hepatitis—Epirubicin—urinary bladder cancer	6.04e-05	0.000504	CcSEcCtD
Morphine—Eye disorder—Methotrexate—urinary bladder cancer	6.03e-05	0.000503	CcSEcCtD
Morphine—Diarrhoea—Fluorouracil—urinary bladder cancer	6.03e-05	0.000503	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—urinary bladder cancer	6.01e-05	0.000501	CcSEcCtD
Morphine—Asthenia—Cisplatin—urinary bladder cancer	6e-05	0.0005	CcSEcCtD
Morphine—Sweating—Doxorubicin—urinary bladder cancer	5.97e-05	0.000498	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—urinary bladder cancer	5.97e-05	0.000498	CcSEcCtD
Morphine—Oedema peripheral—Epirubicin—urinary bladder cancer	5.95e-05	0.000496	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—urinary bladder cancer	5.94e-05	0.000495	CcSEcCtD
Morphine—Urethral disorder—Epirubicin—urinary bladder cancer	5.92e-05	0.000494	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	5.89e-05	0.000491	CcSEcCtD
Morphine—Angiopathy—Methotrexate—urinary bladder cancer	5.86e-05	0.000488	CcSEcCtD
Morphine—Dizziness—Fluorouracil—urinary bladder cancer	5.83e-05	0.000486	CcSEcCtD
Morphine—Visual impairment—Epirubicin—urinary bladder cancer	5.82e-05	0.000486	CcSEcCtD
Morphine—Mediastinal disorder—Methotrexate—urinary bladder cancer	5.82e-05	0.000485	CcSEcCtD
Morphine—Chills—Methotrexate—urinary bladder cancer	5.79e-05	0.000483	CcSEcCtD
Morphine—Diarrhoea—Cisplatin—urinary bladder cancer	5.72e-05	0.000477	CcSEcCtD
Morphine—Vomiting—Gemcitabine—urinary bladder cancer	5.7e-05	0.000476	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—urinary bladder cancer	5.69e-05	0.000475	CcSEcCtD
Morphine—Mental disorder—Methotrexate—urinary bladder cancer	5.66e-05	0.000472	CcSEcCtD
Morphine—Rash—Gemcitabine—urinary bladder cancer	5.65e-05	0.000472	CcSEcCtD
Morphine—Dermatitis—Gemcitabine—urinary bladder cancer	5.65e-05	0.000471	CcSEcCtD
Morphine—Eye disorder—Epirubicin—urinary bladder cancer	5.65e-05	0.000471	CcSEcCtD
Morphine—Hypersensitivity—Etoposide—urinary bladder cancer	5.64e-05	0.000471	CcSEcCtD
Morphine—Erythema—Methotrexate—urinary bladder cancer	5.62e-05	0.000469	CcSEcCtD
Morphine—Malnutrition—Methotrexate—urinary bladder cancer	5.62e-05	0.000469	CcSEcCtD
Morphine—Headache—Gemcitabine—urinary bladder cancer	5.62e-05	0.000469	CcSEcCtD
Morphine—Flushing—Epirubicin—urinary bladder cancer	5.61e-05	0.000468	CcSEcCtD
Morphine—Vomiting—Fluorouracil—urinary bladder cancer	5.61e-05	0.000468	CcSEcCtD
Morphine—Rhinitis—Doxorubicin—urinary bladder cancer	5.61e-05	0.000467	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—urinary bladder cancer	5.59e-05	0.000466	CcSEcCtD
Morphine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	5.56e-05	0.000464	CcSEcCtD
Morphine—Rash—Fluorouracil—urinary bladder cancer	5.56e-05	0.000464	CcSEcCtD
Morphine—Dermatitis—Fluorouracil—urinary bladder cancer	5.55e-05	0.000463	CcSEcCtD
Morphine—Headache—Fluorouracil—urinary bladder cancer	5.52e-05	0.000461	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	5.52e-05	0.00046	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—urinary bladder cancer	5.51e-05	0.000459	CcSEcCtD
Morphine—Dysgeusia—Methotrexate—urinary bladder cancer	5.5e-05	0.000459	CcSEcCtD
Morphine—Asthenia—Etoposide—urinary bladder cancer	5.49e-05	0.000458	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	5.49e-05	0.000458	CcSEcCtD
Morphine—Angiopathy—Epirubicin—urinary bladder cancer	5.48e-05	0.000457	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—urinary bladder cancer	5.48e-05	0.000457	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—urinary bladder cancer	5.45e-05	0.000454	CcSEcCtD
Morphine—Back pain—Methotrexate—urinary bladder cancer	5.44e-05	0.000453	CcSEcCtD
Morphine—Chills—Epirubicin—urinary bladder cancer	5.42e-05	0.000452	CcSEcCtD
Morphine—Pruritus—Etoposide—urinary bladder cancer	5.42e-05	0.000452	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—urinary bladder cancer	5.39e-05	0.000449	CcSEcCtD
Morphine—Nausea—Gemcitabine—urinary bladder cancer	5.33e-05	0.000444	CcSEcCtD
Morphine—Vomiting—Cisplatin—urinary bladder cancer	5.32e-05	0.000443	CcSEcCtD
Morphine—Vision blurred—Methotrexate—urinary bladder cancer	5.3e-05	0.000442	CcSEcCtD
Morphine—Mental disorder—Epirubicin—urinary bladder cancer	5.29e-05	0.000441	CcSEcCtD
Morphine—Rash—Cisplatin—urinary bladder cancer	5.27e-05	0.00044	CcSEcCtD
Morphine—Dermatitis—Cisplatin—urinary bladder cancer	5.27e-05	0.000439	CcSEcCtD
Morphine—Malnutrition—Epirubicin—urinary bladder cancer	5.26e-05	0.000439	CcSEcCtD
Morphine—Erythema—Epirubicin—urinary bladder cancer	5.26e-05	0.000439	CcSEcCtD
Morphine—Diarrhoea—Etoposide—urinary bladder cancer	5.24e-05	0.000437	CcSEcCtD
Morphine—Nausea—Fluorouracil—urinary bladder cancer	5.24e-05	0.000437	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—urinary bladder cancer	5.22e-05	0.000436	CcSEcCtD
Morphine—Ill-defined disorder—Methotrexate—urinary bladder cancer	5.22e-05	0.000435	CcSEcCtD
Morphine—Anaemia—Methotrexate—urinary bladder cancer	5.2e-05	0.000433	CcSEcCtD
Morphine—Flushing—Doxorubicin—urinary bladder cancer	5.19e-05	0.000433	CcSEcCtD
Morphine—Flatulence—Epirubicin—urinary bladder cancer	5.18e-05	0.000432	CcSEcCtD
Morphine—Tension—Epirubicin—urinary bladder cancer	5.16e-05	0.00043	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—urinary bladder cancer	5.15e-05	0.00043	CcSEcCtD
Morphine—Nervousness—Epirubicin—urinary bladder cancer	5.11e-05	0.000426	CcSEcCtD
Morphine—Back pain—Epirubicin—urinary bladder cancer	5.09e-05	0.000424	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—urinary bladder cancer	5.07e-05	0.000423	CcSEcCtD
Morphine—Malaise—Methotrexate—urinary bladder cancer	5.07e-05	0.000423	CcSEcCtD
Morphine—Dizziness—Etoposide—urinary bladder cancer	5.06e-05	0.000422	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—urinary bladder cancer	5.06e-05	0.000422	CcSEcCtD
Morphine—Vertigo—Methotrexate—urinary bladder cancer	5.05e-05	0.000421	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	5.04e-05	0.00042	CcSEcCtD
Morphine—Leukopenia—Methotrexate—urinary bladder cancer	5.03e-05	0.00042	CcSEcCtD
Morphine—Chills—Doxorubicin—urinary bladder cancer	5.02e-05	0.000418	CcSEcCtD
Morphine—Nausea—Cisplatin—urinary bladder cancer	4.97e-05	0.000414	CcSEcCtD
Morphine—Vision blurred—Epirubicin—urinary bladder cancer	4.96e-05	0.000413	CcSEcCtD
Morphine—Cough—Methotrexate—urinary bladder cancer	4.9e-05	0.000409	CcSEcCtD
Morphine—Mental disorder—Doxorubicin—urinary bladder cancer	4.9e-05	0.000408	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—urinary bladder cancer	4.88e-05	0.000407	CcSEcCtD
Morphine—Convulsion—Methotrexate—urinary bladder cancer	4.87e-05	0.000406	CcSEcCtD
Morphine—Vomiting—Etoposide—urinary bladder cancer	4.87e-05	0.000406	CcSEcCtD
Morphine—Erythema—Doxorubicin—urinary bladder cancer	4.87e-05	0.000406	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—urinary bladder cancer	4.87e-05	0.000406	CcSEcCtD
Morphine—Anaemia—Epirubicin—urinary bladder cancer	4.86e-05	0.000405	CcSEcCtD
Morphine—Agitation—Epirubicin—urinary bladder cancer	4.83e-05	0.000403	CcSEcCtD
Morphine—Rash—Etoposide—urinary bladder cancer	4.83e-05	0.000403	CcSEcCtD
Morphine—Dermatitis—Etoposide—urinary bladder cancer	4.82e-05	0.000402	CcSEcCtD
Morphine—Headache—Etoposide—urinary bladder cancer	4.8e-05	0.0004	CcSEcCtD
Morphine—Flatulence—Doxorubicin—urinary bladder cancer	4.8e-05	0.0004	CcSEcCtD
Morphine—Arthralgia—Methotrexate—urinary bladder cancer	4.79e-05	0.000399	CcSEcCtD
Morphine—Chest pain—Methotrexate—urinary bladder cancer	4.79e-05	0.000399	CcSEcCtD
Morphine—Tension—Doxorubicin—urinary bladder cancer	4.78e-05	0.000398	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—urinary bladder cancer	4.77e-05	0.000397	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	4.75e-05	0.000396	CcSEcCtD
Morphine—Malaise—Epirubicin—urinary bladder cancer	4.74e-05	0.000396	CcSEcCtD
Morphine—Discomfort—Methotrexate—urinary bladder cancer	4.73e-05	0.000394	CcSEcCtD
Morphine—Nervousness—Doxorubicin—urinary bladder cancer	4.73e-05	0.000394	CcSEcCtD
Morphine—Vertigo—Epirubicin—urinary bladder cancer	4.73e-05	0.000394	CcSEcCtD
Morphine—Syncope—Epirubicin—urinary bladder cancer	4.72e-05	0.000393	CcSEcCtD
Morphine—Leukopenia—Epirubicin—urinary bladder cancer	4.71e-05	0.000393	CcSEcCtD
Morphine—Back pain—Doxorubicin—urinary bladder cancer	4.71e-05	0.000393	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—urinary bladder cancer	4.68e-05	0.00039	CcSEcCtD
Morphine—Palpitations—Epirubicin—urinary bladder cancer	4.65e-05	0.000388	CcSEcCtD
Morphine—Confusional state—Methotrexate—urinary bladder cancer	4.63e-05	0.000386	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—urinary bladder cancer	4.62e-05	0.000386	CcSEcCtD
Morphine—Cough—Epirubicin—urinary bladder cancer	4.59e-05	0.000383	CcSEcCtD
Morphine—Anaphylactic shock—Methotrexate—urinary bladder cancer	4.59e-05	0.000383	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—urinary bladder cancer	4.59e-05	0.000382	CcSEcCtD
Morphine—Convulsion—Epirubicin—urinary bladder cancer	4.56e-05	0.00038	CcSEcCtD
Morphine—Infection—Methotrexate—urinary bladder cancer	4.56e-05	0.00038	CcSEcCtD
Morphine—Nausea—Etoposide—urinary bladder cancer	4.55e-05	0.000379	CcSEcCtD
Morphine—Hypertension—Epirubicin—urinary bladder cancer	4.54e-05	0.000379	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	4.52e-05	0.000377	CcSEcCtD
Morphine—Nervous system disorder—Methotrexate—urinary bladder cancer	4.5e-05	0.000375	CcSEcCtD
Morphine—Anaemia—Doxorubicin—urinary bladder cancer	4.5e-05	0.000375	CcSEcCtD
Morphine—Thrombocytopenia—Methotrexate—urinary bladder cancer	4.49e-05	0.000375	CcSEcCtD
Morphine—Chest pain—Epirubicin—urinary bladder cancer	4.48e-05	0.000373	CcSEcCtD
Morphine—Arthralgia—Epirubicin—urinary bladder cancer	4.48e-05	0.000373	CcSEcCtD
Morphine—Agitation—Doxorubicin—urinary bladder cancer	4.47e-05	0.000373	CcSEcCtD
Morphine—Anxiety—Epirubicin—urinary bladder cancer	4.46e-05	0.000372	CcSEcCtD
Morphine—Skin disorder—Methotrexate—urinary bladder cancer	4.46e-05	0.000372	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	4.45e-05	0.000371	CcSEcCtD
Morphine—Hyperhidrosis—Methotrexate—urinary bladder cancer	4.43e-05	0.00037	CcSEcCtD
Morphine—Discomfort—Epirubicin—urinary bladder cancer	4.42e-05	0.000369	CcSEcCtD
Morphine—Malaise—Doxorubicin—urinary bladder cancer	4.39e-05	0.000366	CcSEcCtD
Morphine—Dry mouth—Epirubicin—urinary bladder cancer	4.38e-05	0.000365	CcSEcCtD
Morphine—Vertigo—Doxorubicin—urinary bladder cancer	4.37e-05	0.000365	CcSEcCtD
Morphine—Anorexia—Methotrexate—urinary bladder cancer	4.37e-05	0.000365	CcSEcCtD
Morphine—Syncope—Doxorubicin—urinary bladder cancer	4.36e-05	0.000364	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—urinary bladder cancer	4.36e-05	0.000363	CcSEcCtD
Morphine—Confusional state—Epirubicin—urinary bladder cancer	4.33e-05	0.000361	CcSEcCtD
Morphine—Palpitations—Doxorubicin—urinary bladder cancer	4.3e-05	0.000359	CcSEcCtD
Morphine—Oedema—Epirubicin—urinary bladder cancer	4.29e-05	0.000358	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—urinary bladder cancer	4.29e-05	0.000358	CcSEcCtD
Morphine—Hypotension—Methotrexate—urinary bladder cancer	4.29e-05	0.000357	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—urinary bladder cancer	4.28e-05	0.000357	CcSEcCtD
Morphine—Infection—Epirubicin—urinary bladder cancer	4.26e-05	0.000356	CcSEcCtD
Morphine—Cough—Doxorubicin—urinary bladder cancer	4.25e-05	0.000354	CcSEcCtD
Morphine—Shock—Epirubicin—urinary bladder cancer	4.22e-05	0.000352	CcSEcCtD
Morphine—Convulsion—Doxorubicin—urinary bladder cancer	4.22e-05	0.000352	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—urinary bladder cancer	4.21e-05	0.000351	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—urinary bladder cancer	4.2e-05	0.00035	CcSEcCtD
Morphine—Hypertension—Doxorubicin—urinary bladder cancer	4.2e-05	0.00035	CcSEcCtD
Morphine—Tachycardia—Epirubicin—urinary bladder cancer	4.19e-05	0.000349	CcSEcCtD
Morphine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	4.18e-05	0.000349	CcSEcCtD
Morphine—Skin disorder—Epirubicin—urinary bladder cancer	4.17e-05	0.000348	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—urinary bladder cancer	4.15e-05	0.000346	CcSEcCtD
Morphine—Insomnia—Methotrexate—urinary bladder cancer	4.15e-05	0.000346	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—urinary bladder cancer	4.14e-05	0.000346	CcSEcCtD
Morphine—Chest pain—Doxorubicin—urinary bladder cancer	4.14e-05	0.000346	CcSEcCtD
Morphine—Anxiety—Doxorubicin—urinary bladder cancer	4.13e-05	0.000344	CcSEcCtD
Morphine—Paraesthesia—Methotrexate—urinary bladder cancer	4.12e-05	0.000343	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	4.12e-05	0.000343	CcSEcCtD
Morphine—Discomfort—Doxorubicin—urinary bladder cancer	4.09e-05	0.000341	CcSEcCtD
Morphine—Anorexia—Epirubicin—urinary bladder cancer	4.09e-05	0.000341	CcSEcCtD
Morphine—Dyspnoea—Methotrexate—urinary bladder cancer	4.09e-05	0.000341	CcSEcCtD
Morphine—Somnolence—Methotrexate—urinary bladder cancer	4.08e-05	0.00034	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—urinary bladder cancer	4.05e-05	0.000338	CcSEcCtD
Morphine—Dyspepsia—Methotrexate—urinary bladder cancer	4.04e-05	0.000337	CcSEcCtD
Morphine—Hypotension—Epirubicin—urinary bladder cancer	4.01e-05	0.000334	CcSEcCtD
Morphine—Confusional state—Doxorubicin—urinary bladder cancer	4.01e-05	0.000334	CcSEcCtD
Morphine—Decreased appetite—Methotrexate—urinary bladder cancer	3.99e-05	0.000333	CcSEcCtD
Morphine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.97e-05	0.000331	CcSEcCtD
Morphine—Oedema—Doxorubicin—urinary bladder cancer	3.97e-05	0.000331	CcSEcCtD
Morphine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.96e-05	0.00033	CcSEcCtD
Morphine—Fatigue—Methotrexate—urinary bladder cancer	3.95e-05	0.00033	CcSEcCtD
Morphine—Infection—Doxorubicin—urinary bladder cancer	3.95e-05	0.000329	CcSEcCtD
Morphine—Pain—Methotrexate—urinary bladder cancer	3.92e-05	0.000327	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.91e-05	0.000326	CcSEcCtD
Morphine—Shock—Doxorubicin—urinary bladder cancer	3.91e-05	0.000326	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.9e-05	0.000325	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.89e-05	0.000324	CcSEcCtD
Morphine—Insomnia—Epirubicin—urinary bladder cancer	3.88e-05	0.000324	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—urinary bladder cancer	3.88e-05	0.000323	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—urinary bladder cancer	3.86e-05	0.000322	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—urinary bladder cancer	3.85e-05	0.000321	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.84e-05	0.00032	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—urinary bladder cancer	3.83e-05	0.000319	CcSEcCtD
Morphine—Somnolence—Epirubicin—urinary bladder cancer	3.82e-05	0.000318	CcSEcCtD
Morphine—Anorexia—Doxorubicin—urinary bladder cancer	3.79e-05	0.000316	CcSEcCtD
Morphine—Feeling abnormal—Methotrexate—urinary bladder cancer	3.78e-05	0.000315	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—urinary bladder cancer	3.78e-05	0.000315	CcSEcCtD
Morphine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.75e-05	0.000313	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—urinary bladder cancer	3.73e-05	0.000311	CcSEcCtD
Morphine—Hypotension—Doxorubicin—urinary bladder cancer	3.71e-05	0.00031	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.71e-05	0.000309	CcSEcCtD
Morphine—Fatigue—Epirubicin—urinary bladder cancer	3.7e-05	0.000309	CcSEcCtD
Morphine—Constipation—Epirubicin—urinary bladder cancer	3.67e-05	0.000306	CcSEcCtD
Morphine—Pain—Epirubicin—urinary bladder cancer	3.67e-05	0.000306	CcSEcCtD
Morphine—Urticaria—Methotrexate—urinary bladder cancer	3.64e-05	0.000304	CcSEcCtD
Morphine—Abdominal pain—Methotrexate—urinary bladder cancer	3.63e-05	0.000302	CcSEcCtD
Morphine—Body temperature increased—Methotrexate—urinary bladder cancer	3.63e-05	0.000302	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.62e-05	0.000302	CcSEcCtD
Morphine—Insomnia—Doxorubicin—urinary bladder cancer	3.59e-05	0.0003	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—urinary bladder cancer	3.57e-05	0.000297	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—urinary bladder cancer	3.54e-05	0.000295	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—urinary bladder cancer	3.54e-05	0.000295	CcSEcCtD
Morphine—Somnolence—Doxorubicin—urinary bladder cancer	3.53e-05	0.000294	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.51e-05	0.000293	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—urinary bladder cancer	3.5e-05	0.000292	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—urinary bladder cancer	3.45e-05	0.000288	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	3.43e-05	0.000286	CcSEcCtD
Morphine—Fatigue—Doxorubicin—urinary bladder cancer	3.42e-05	0.000286	CcSEcCtD
Morphine—Urticaria—Epirubicin—urinary bladder cancer	3.41e-05	0.000284	CcSEcCtD
Morphine—Pain—Doxorubicin—urinary bladder cancer	3.4e-05	0.000283	CcSEcCtD
Morphine—Constipation—Doxorubicin—urinary bladder cancer	3.4e-05	0.000283	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—urinary bladder cancer	3.39e-05	0.000283	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—urinary bladder cancer	3.39e-05	0.000283	CcSEcCtD
Morphine—Hypersensitivity—Methotrexate—urinary bladder cancer	3.38e-05	0.000282	CcSEcCtD
Morphine—Asthenia—Methotrexate—urinary bladder cancer	3.29e-05	0.000274	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—urinary bladder cancer	3.27e-05	0.000273	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	3.25e-05	0.000271	CcSEcCtD
Morphine—Pruritus—Methotrexate—urinary bladder cancer	3.25e-05	0.000271	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—urinary bladder cancer	3.16e-05	0.000264	CcSEcCtD
Morphine—Urticaria—Doxorubicin—urinary bladder cancer	3.16e-05	0.000263	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—urinary bladder cancer	3.14e-05	0.000262	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—urinary bladder cancer	3.14e-05	0.000262	CcSEcCtD
Morphine—Diarrhoea—Methotrexate—urinary bladder cancer	3.14e-05	0.000262	CcSEcCtD
Morphine—Asthenia—Epirubicin—urinary bladder cancer	3.08e-05	0.000257	CcSEcCtD
Morphine—Pruritus—Epirubicin—urinary bladder cancer	3.04e-05	0.000253	CcSEcCtD
Morphine—Dizziness—Methotrexate—urinary bladder cancer	3.03e-05	0.000253	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—urinary bladder cancer	2.94e-05	0.000245	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.93e-05	0.000244	CcSEcCtD
Morphine—Vomiting—Methotrexate—urinary bladder cancer	2.92e-05	0.000243	CcSEcCtD
Morphine—Rash—Methotrexate—urinary bladder cancer	2.89e-05	0.000241	CcSEcCtD
Morphine—Dermatitis—Methotrexate—urinary bladder cancer	2.89e-05	0.000241	CcSEcCtD
Morphine—Headache—Methotrexate—urinary bladder cancer	2.87e-05	0.00024	CcSEcCtD
Morphine—Asthenia—Doxorubicin—urinary bladder cancer	2.85e-05	0.000238	CcSEcCtD
Morphine—Dizziness—Epirubicin—urinary bladder cancer	2.84e-05	0.000237	CcSEcCtD
Morphine—Pruritus—Doxorubicin—urinary bladder cancer	2.81e-05	0.000234	CcSEcCtD
Morphine—Vomiting—Epirubicin—urinary bladder cancer	2.73e-05	0.000228	CcSEcCtD
Morphine—Nausea—Methotrexate—urinary bladder cancer	2.72e-05	0.000227	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.72e-05	0.000227	CcSEcCtD
Morphine—Rash—Epirubicin—urinary bladder cancer	2.71e-05	0.000226	CcSEcCtD
Morphine—Dermatitis—Epirubicin—urinary bladder cancer	2.7e-05	0.000225	CcSEcCtD
Morphine—Headache—Epirubicin—urinary bladder cancer	2.69e-05	0.000224	CcSEcCtD
Morphine—Dizziness—Doxorubicin—urinary bladder cancer	2.63e-05	0.000219	CcSEcCtD
Morphine—Nausea—Epirubicin—urinary bladder cancer	2.55e-05	0.000213	CcSEcCtD
Morphine—Vomiting—Doxorubicin—urinary bladder cancer	2.53e-05	0.000211	CcSEcCtD
Morphine—Rash—Doxorubicin—urinary bladder cancer	2.5e-05	0.000209	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—urinary bladder cancer	2.5e-05	0.000209	CcSEcCtD
Morphine—Headache—Doxorubicin—urinary bladder cancer	2.49e-05	0.000208	CcSEcCtD
Morphine—Nausea—Doxorubicin—urinary bladder cancer	2.36e-05	0.000197	CcSEcCtD
Morphine—OPRL1—Signaling Pathways—IL2—urinary bladder cancer	1.21e-05	0.000118	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTP1—urinary bladder cancer	1.2e-05	0.000117	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—JAG1—urinary bladder cancer	1.19e-05	0.000116	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTEN—urinary bladder cancer	1.19e-05	0.000116	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTEN—urinary bladder cancer	1.19e-05	0.000116	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	1.18e-05	0.000115	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCND1—urinary bladder cancer	1.18e-05	0.000115	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	1.18e-05	0.000114	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NQO1—urinary bladder cancer	1.17e-05	0.000114	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	1.15e-05	0.000112	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.15e-05	0.000111	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	0.000111	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MMP9—urinary bladder cancer	1.15e-05	0.000111	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.14e-05	0.000111	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTEN—urinary bladder cancer	1.14e-05	0.000111	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—EP300—urinary bladder cancer	1.14e-05	0.00011	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—EP300—urinary bladder cancer	1.14e-05	0.00011	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	1.13e-05	0.000109	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RBX1—urinary bladder cancer	1.13e-05	0.000109	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—TYMS—urinary bladder cancer	1.12e-05	0.000108	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	1.12e-05	0.000108	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—NCOR1—urinary bladder cancer	1.1e-05	0.000107	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GSTM1—urinary bladder cancer	1.1e-05	0.000107	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—S100B—urinary bladder cancer	1.1e-05	0.000107	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	1.09e-05	0.000106	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	1.09e-05	0.000106	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EP300—urinary bladder cancer	1.09e-05	0.000105	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	1.09e-05	0.000105	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.06e-05	0.000103	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TSC1—urinary bladder cancer	1.06e-05	0.000103	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMP—urinary bladder cancer	1.06e-05	0.000103	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—SRC—urinary bladder cancer	1.06e-05	0.000103	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—GPX1—urinary bladder cancer	1.06e-05	0.000103	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—RHOA—urinary bladder cancer	1.04e-05	0.000101	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—ERCC2—urinary bladder cancer	1.04e-05	0.000101	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.04e-05	0.000101	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.02e-05	9.85e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.01e-05	9.79e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.01e-05	9.79e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—RHOA—urinary bladder cancer	1.01e-05	9.77e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—JAG1—urinary bladder cancer	1.01e-05	9.77e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NCOR1—urinary bladder cancer	9.9e-06	9.6e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	9.89e-06	9.59e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTP1—urinary bladder cancer	9.77e-06	9.47e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—MTHFR—urinary bladder cancer	9.76e-06	9.46e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—S100B—urinary bladder cancer	9.66e-06	9.36e-05	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—IL2—urinary bladder cancer	9.65e-06	9.35e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NAT2—urinary bladder cancer	9.57e-06	9.28e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—MYC—urinary bladder cancer	9.48e-06	9.19e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	9.38e-06	9.09e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	9.38e-06	9.09e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PPARG—urinary bladder cancer	9.31e-06	9.03e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EGFR—urinary bladder cancer	9.27e-06	8.99e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMP—urinary bladder cancer	9.22e-06	8.94e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—urinary bladder cancer	9.17e-06	8.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—RHOA—urinary bladder cancer	9.16e-06	8.88e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—TYMS—urinary bladder cancer	9.08e-06	8.8e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	9.05e-06	8.77e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GSTM1—urinary bladder cancer	8.98e-06	8.7e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—NCOR1—urinary bladder cancer	8.98e-06	8.7e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	8.94e-06	8.67e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—urinary bladder cancer	8.85e-06	8.58e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	8.85e-06	8.58e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—IL2—urinary bladder cancer	8.76e-06	8.49e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—urinary bladder cancer	8.76e-06	8.49e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TERT—urinary bladder cancer	8.73e-06	8.46e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	8.69e-06	8.42e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NCOR1—urinary bladder cancer	8.69e-06	8.42e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—GPX1—urinary bladder cancer	8.6e-06	8.33e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	8.58e-06	8.31e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—RHOA—urinary bladder cancer	8.52e-06	8.26e-05	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—IL2—urinary bladder cancer	8.46e-06	8.2e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—ERCC2—urinary bladder cancer	8.44e-06	8.18e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	8.43e-06	8.17e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.36e-06	8.1e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NAT2—urinary bladder cancer	8.34e-06	8.08e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—RRM2—urinary bladder cancer	8.26e-06	8.01e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—S100B—urinary bladder cancer	8.16e-06	7.91e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—urinary bladder cancer	8.04e-06	7.79e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FGFR3—urinary bladder cancer	8.01e-06	7.76e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—MTHFR—urinary bladder cancer	7.93e-06	7.69e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PPARG—urinary bladder cancer	7.92e-06	7.67e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	7.86e-06	7.62e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—urinary bladder cancer	7.79e-06	7.55e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ESR1—urinary bladder cancer	7.78e-06	7.54e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—RHOA—urinary bladder cancer	7.74e-06	7.5e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	7.72e-06	7.48e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—IL2—urinary bladder cancer	7.68e-06	7.45e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TERT—urinary bladder cancer	7.65e-06	7.42e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	7.65e-06	7.42e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ENO2—urinary bladder cancer	7.65e-06	7.42e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.61e-06	7.37e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CREBBP—urinary bladder cancer	7.61e-06	7.37e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—urinary bladder cancer	7.48e-06	7.25e-05	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—urinary bladder cancer	7.45e-06	7.22e-05	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.43e-06	7.2e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	7.42e-06	7.19e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NCOR1—urinary bladder cancer	7.34e-06	7.12e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	7.32e-06	7.1e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.31e-06	7.08e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	7.29e-06	7.07e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—RRM2—urinary bladder cancer	7.2e-06	6.98e-05	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—IL2—urinary bladder cancer	7.15e-06	6.93e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	7.11e-06	6.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGFR3—urinary bladder cancer	7.02e-06	6.81e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ESR1—urinary bladder cancer	6.82e-06	6.61e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CREBBP—urinary bladder cancer	6.82e-06	6.61e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—urinary bladder cancer	6.79e-06	6.59e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	6.78e-06	6.57e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1—urinary bladder cancer	6.73e-06	6.53e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—EGFR—urinary bladder cancer	6.7e-06	6.5e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ENO2—urinary bladder cancer	6.67e-06	6.46e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	6.67e-06	6.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—IL2—urinary bladder cancer	6.49e-06	6.29e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TERT—urinary bladder cancer	6.47e-06	6.27e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	6.47e-06	6.27e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PPARG—urinary bladder cancer	6.43e-06	6.24e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—urinary bladder cancer	6.39e-06	6.19e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—urinary bladder cancer	6.33e-06	6.14e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	6.28e-06	6.09e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	6.28e-06	6.09e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTGS2—urinary bladder cancer	6.23e-06	6.04e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CREBBP—urinary bladder cancer	6.18e-06	5.99e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—RHOA—urinary bladder cancer	6.17e-06	5.98e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	6.17e-06	5.98e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	6.09e-06	5.91e-05	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—EP300—urinary bladder cancer	6.09e-06	5.91e-05	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.05e-06	5.87e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.98e-06	5.8e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CREBBP—urinary bladder cancer	5.98e-06	5.8e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGFR3—urinary bladder cancer	5.94e-06	5.75e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1—urinary bladder cancer	5.9e-06	5.72e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—EGFR—urinary bladder cancer	5.88e-06	5.7e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ESR1—urinary bladder cancer	5.77e-06	5.59e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—urinary bladder cancer	5.71e-06	5.54e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	5.68e-06	5.51e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—urinary bladder cancer	5.55e-06	5.38e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—urinary bladder cancer	5.43e-06	5.26e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—urinary bladder cancer	5.42e-06	5.25e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—RHOA—urinary bladder cancer	5.41e-06	5.24e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—urinary bladder cancer	5.38e-06	5.22e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NQO1—urinary bladder cancer	5.37e-06	5.21e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.22e-06	5.06e-05	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—urinary bladder cancer	5.18e-06	5.02e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IL2—urinary bladder cancer	5.18e-06	5.02e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	5.14e-06	4.99e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	5.14e-06	4.98e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	5.06e-06	4.91e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTGS2—urinary bladder cancer	5.06e-06	4.91e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CREBBP—urinary bladder cancer	5.05e-06	4.9e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCND1—urinary bladder cancer	5.05e-06	4.89e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—urinary bladder cancer	5.01e-06	4.85e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1—urinary bladder cancer	4.99e-06	4.84e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.98e-06	4.82e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—EGFR—urinary bladder cancer	4.97e-06	4.81e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MMP9—urinary bladder cancer	4.9e-06	4.75e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.88e-06	4.73e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—urinary bladder cancer	4.87e-06	4.72e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	4.78e-06	4.64e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—urinary bladder cancer	4.75e-06	4.6e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	4.73e-06	4.58e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	4.73e-06	4.58e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—urinary bladder cancer	4.72e-06	4.57e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—urinary bladder cancer	4.69e-06	4.55e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—urinary bladder cancer	4.64e-06	4.5e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—RHOA—urinary bladder cancer	4.57e-06	4.43e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IL2—urinary bladder cancer	4.54e-06	4.4e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	4.53e-06	4.39e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SRC—urinary bladder cancer	4.52e-06	4.38e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	4.48e-06	4.34e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	4.44e-06	4.31e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	4.43e-06	4.3e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCND1—urinary bladder cancer	4.42e-06	4.29e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—urinary bladder cancer	4.41e-06	4.28e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MMP9—urinary bladder cancer	4.3e-06	4.16e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1A—urinary bladder cancer	4.28e-06	4.15e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—urinary bladder cancer	4.27e-06	4.14e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—urinary bladder cancer	4.23e-06	4.1e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	4.22e-06	4.09e-05	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—urinary bladder cancer	4.21e-06	4.08e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	4.18e-06	4.05e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—TYMS—urinary bladder cancer	4.17e-06	4.04e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	4.12e-06	3.99e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	4.12e-06	3.99e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	4.11e-06	3.98e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	4.11e-06	3.98e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—urinary bladder cancer	4.07e-06	3.95e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—MYC—urinary bladder cancer	4.05e-06	3.92e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—urinary bladder cancer	4.01e-06	3.89e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—urinary bladder cancer	3.99e-06	3.87e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.98e-06	3.86e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SRC—urinary bladder cancer	3.96e-06	3.84e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EGFR—urinary bladder cancer	3.96e-06	3.84e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—GPX1—urinary bladder cancer	3.94e-06	3.82e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.93e-06	3.81e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.88e-06	3.76e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.88e-06	3.76e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	3.87e-06	3.75e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IL2—urinary bladder cancer	3.84e-06	3.72e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—urinary bladder cancer	3.74e-06	3.62e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCND1—urinary bladder cancer	3.74e-06	3.62e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.72e-06	3.6e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.65e-06	3.54e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	3.64e-06	3.53e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MMP9—urinary bladder cancer	3.63e-06	3.52e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	3.62e-06	3.51e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—urinary bladder cancer	3.61e-06	3.5e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—MYC—urinary bladder cancer	3.55e-06	3.44e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EGFR—urinary bladder cancer	3.47e-06	3.36e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—urinary bladder cancer	3.44e-06	3.34e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.43e-06	3.32e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	3.39e-06	3.28e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SRC—urinary bladder cancer	3.35e-06	3.24e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—urinary bladder cancer	3.32e-06	3.22e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	3.31e-06	3.21e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—urinary bladder cancer	3.28e-06	3.18e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	3.25e-06	3.15e-05	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—urinary bladder cancer	3.18e-06	3.08e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—MYC—urinary bladder cancer	3e-06	2.91e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.95e-06	2.86e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EGFR—urinary bladder cancer	2.93e-06	2.84e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—urinary bladder cancer	2.91e-06	2.82e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	2.84e-06	2.75e-05	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—urinary bladder cancer	2.79e-06	2.7e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.78e-06	2.7e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—urinary bladder cancer	2.77e-06	2.69e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.76e-06	2.68e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.67e-06	2.59e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	2.66e-06	2.58e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	2.57e-06	2.49e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	2.54e-06	2.46e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	2.54e-06	2.46e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—urinary bladder cancer	2.46e-06	2.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	2.43e-06	2.36e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.39e-06	2.31e-05	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—urinary bladder cancer	2.36e-06	2.28e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.32e-06	2.25e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.32e-06	2.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.24e-06	2.17e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.22e-06	2.15e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.19e-06	2.12e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.02e-06	1.96e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.93e-06	1.87e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.91e-06	1.85e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.82e-06	1.76e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.82e-06	1.76e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.75e-06	1.69e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.43e-06	1.39e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.25e-06	1.21e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.19e-06	1.15e-05	CbGpPWpGaD
